albumin: decreased in multiple myeloma

from Quasimodo
0.2 0.4 0.6 0.8 Plausible Typical Remarkable Salient

Related concepts

Parents molecule
Weight: 0.69
, protein
Weight: 0.67
, substance
Weight: 0.56
, colloid
Weight: 0.54
, agent
Weight: 0.54
Siblings hemoglobin
Weight: 0.37
, rna molecule
Weight: 0.37
, adenosine triphosphate
Weight: 0.37
, dna molecule
Weight: 0.36
, peptide
Weight: 0.36

Related properties

Property Similarity
decreased in multiple myeloma 1.00
decreased in myeloma 0.98
decreased in sepsis 0.84
decreased in liver disease 0.82
be decreased in liver disease 0.82
decreased in renal failure 0.79
be decreased in cirrhosis 0.79
be low in cancer patients 0.78
decreased esr 0.77
be decreased in inflammation 0.77

Priors about this statement

Cues

0.2 0.4 0.6 0.8 Joint Necessity Sufficiency Implication Entailment Contradiction Entropy

Evidence

0.2 0.4 0.6 0.8 Plausible Typical Remarkable Salient

Clauses

Remarkability exclusitivity between siblings

0.09
Rule weight: 0.13
Evidence weight: 0.87
Similarity weight: 0.78
Evidence: 0.55
¬ Remarkable(albumin, decreased in multiple myeloma) ⋁
Evidence: 0.24
¬ Remarkable(hemoglobin, be low in cancer patients)

Remarkability from sibling implausibility

0.40
Rule weight: 0.60
Evidence weight: 0.86
Similarity weight: 0.78
Evidence: 0.67
Plausible(albumin, decreased in multiple myeloma) ⋁
Evidence: 0.24
Remarkable(hemoglobin, be low in cancer patients) ⋁
Evidence: 0.55
¬ Plausible(hemoglobin, be low in cancer patients)

Salient implies Plausible

0.22
Rule weight: 0.28
Evidence weight: 0.77
Similarity weight: 1.00
Evidence: 0.67
Plausible(albumin, decreased in multiple myeloma) ⋁
Evidence: 0.71
¬ Salient(albumin, decreased in multiple myeloma)

Similarity expansion

0.61
Rule weight: 0.85
Evidence weight: 0.93
Similarity weight: 0.77
Evidence: 0.71
Salient(albumin, decreased in multiple myeloma) ⋁
Evidence: 0.25
¬ Salient(albumin, decreased esr)
0.60
Rule weight: 0.85
Evidence weight: 0.92
Similarity weight: 0.77
Evidence: 0.67
Plausible(albumin, decreased in multiple myeloma) ⋁
Evidence: 0.26
¬ Plausible(albumin, decreased esr)
0.59
Rule weight: 0.85
Evidence weight: 0.90
Similarity weight: 0.77
Evidence: 0.72
Typical(albumin, decreased in multiple myeloma) ⋁
Evidence: 0.37
¬ Typical(albumin, decreased esr)
0.58
Rule weight: 0.85
Evidence weight: 0.82
Similarity weight: 0.84
Evidence: 0.72
Typical(albumin, decreased in multiple myeloma) ⋁
Evidence: 0.67
¬ Typical(albumin, decreased in sepsis)
0.57
Rule weight: 0.85
Evidence weight: 0.86
Similarity weight: 0.77
Evidence: 0.55
Remarkable(albumin, decreased in multiple myeloma) ⋁
Evidence: 0.31
¬ Remarkable(albumin, decreased esr)
0.56
Rule weight: 0.85
Evidence weight: 0.79
Similarity weight: 0.84
Evidence: 0.67
Plausible(albumin, decreased in multiple myeloma) ⋁
Evidence: 0.65
¬ Plausible(albumin, decreased in sepsis)
0.56
Rule weight: 0.85
Evidence weight: 0.79
Similarity weight: 0.84
Evidence: 0.71
Salient(albumin, decreased in multiple myeloma) ⋁
Evidence: 0.73
¬ Salient(albumin, decreased in sepsis)
0.55
Rule weight: 0.85
Evidence weight: 0.83
Similarity weight: 0.78
Evidence: 0.55
Remarkable(albumin, decreased in multiple myeloma) ⋁
Evidence: 0.37
¬ Remarkable(albumin, be low in cancer patients)
0.55
Rule weight: 0.85
Evidence weight: 0.79
Similarity weight: 0.82
Evidence: 0.72
Typical(albumin, decreased in multiple myeloma) ⋁
Evidence: 0.75
¬ Typical(albumin, decreased in liver disease)
0.55
Rule weight: 0.85
Evidence weight: 0.82
Similarity weight: 0.79
Evidence: 0.71
Salient(albumin, decreased in multiple myeloma) ⋁
Evidence: 0.63
¬ Salient(albumin, decreased in renal failure)
0.55
Rule weight: 0.85
Evidence weight: 0.79
Similarity weight: 0.82
Evidence: 0.71
Salient(albumin, decreased in multiple myeloma) ⋁
Evidence: 0.74
¬ Salient(albumin, be decreased in liver disease)
0.55
Rule weight: 0.85
Evidence weight: 0.81
Similarity weight: 0.79
Evidence: 0.72
Typical(albumin, decreased in multiple myeloma) ⋁
Evidence: 0.68
¬ Typical(albumin, decreased in renal failure)
0.55
Rule weight: 0.85
Evidence weight: 0.78
Similarity weight: 0.82
Evidence: 0.55
Remarkable(albumin, decreased in multiple myeloma) ⋁
Evidence: 0.48
¬ Remarkable(albumin, be decreased in liver disease)
0.54
Rule weight: 0.85
Evidence weight: 0.78
Similarity weight: 0.82
Evidence: 0.71
Salient(albumin, decreased in multiple myeloma) ⋁
Evidence: 0.76
¬ Salient(albumin, decreased in liver disease)
0.54
Rule weight: 0.85
Evidence weight: 0.80
Similarity weight: 0.79
Evidence: 0.72
Typical(albumin, decreased in multiple myeloma) ⋁
Evidence: 0.71
¬ Typical(albumin, be decreased in cirrhosis)
0.54
Rule weight: 0.85
Evidence weight: 0.77
Similarity weight: 0.82
Evidence: 0.72
Typical(albumin, decreased in multiple myeloma) ⋁
Evidence: 0.82
¬ Typical(albumin, be decreased in liver disease)
0.54
Rule weight: 0.85
Evidence weight: 0.80
Similarity weight: 0.79
Evidence: 0.67
Plausible(albumin, decreased in multiple myeloma) ⋁
Evidence: 0.61
¬ Plausible(albumin, decreased in renal failure)
0.54
Rule weight: 0.85
Evidence weight: 0.77
Similarity weight: 0.82
Evidence: 0.67
Plausible(albumin, decreased in multiple myeloma) ⋁
Evidence: 0.69
¬ Plausible(albumin, decreased in liver disease)
0.53
Rule weight: 0.85
Evidence weight: 0.79
Similarity weight: 0.79
Evidence: 0.71
Salient(albumin, decreased in multiple myeloma) ⋁
Evidence: 0.71
¬ Salient(albumin, be decreased in cirrhosis)
0.53
Rule weight: 0.85
Evidence weight: 0.76
Similarity weight: 0.82
Evidence: 0.67
Plausible(albumin, decreased in multiple myeloma) ⋁
Evidence: 0.72
¬ Plausible(albumin, be decreased in liver disease)
0.53
Rule weight: 0.85
Evidence weight: 0.81
Similarity weight: 0.77
Evidence: 0.72
Typical(albumin, decreased in multiple myeloma) ⋁
Evidence: 0.68
¬ Typical(albumin, be decreased in inflammation)
0.53
Rule weight: 0.85
Evidence weight: 0.78
Similarity weight: 0.79
Evidence: 0.67
Plausible(albumin, decreased in multiple myeloma) ⋁
Evidence: 0.67
¬ Plausible(albumin, be decreased in cirrhosis)
0.52
Rule weight: 0.85
Evidence weight: 0.77
Similarity weight: 0.79
Evidence: 0.55
Remarkable(albumin, decreased in multiple myeloma) ⋁
Evidence: 0.51
¬ Remarkable(albumin, decreased in renal failure)
0.52
Rule weight: 0.85
Evidence weight: 0.78
Similarity weight: 0.78
Evidence: 0.71
Salient(albumin, decreased in multiple myeloma) ⋁
Evidence: 0.75
¬ Salient(albumin, be low in cancer patients)
0.51
Rule weight: 0.85
Evidence weight: 0.73
Similarity weight: 0.82
Evidence: 0.55
Remarkable(albumin, decreased in multiple myeloma) ⋁
Evidence: 0.59
¬ Remarkable(albumin, decreased in liver disease)
0.51
Rule weight: 0.85
Evidence weight: 0.78
Similarity weight: 0.77
Evidence: 0.67
Plausible(albumin, decreased in multiple myeloma) ⋁
Evidence: 0.68
¬ Plausible(albumin, be decreased in inflammation)
0.51
Rule weight: 0.85
Evidence weight: 0.78
Similarity weight: 0.77
Evidence: 0.71
Salient(albumin, decreased in multiple myeloma) ⋁
Evidence: 0.77
¬ Salient(albumin, be decreased in inflammation)
0.50
Rule weight: 0.85
Evidence weight: 0.70
Similarity weight: 0.84
Evidence: 0.55
Remarkable(albumin, decreased in multiple myeloma) ⋁
Evidence: 0.66
¬ Remarkable(albumin, decreased in sepsis)
0.50
Rule weight: 0.85
Evidence weight: 0.74
Similarity weight: 0.79
Evidence: 0.55
Remarkable(albumin, decreased in multiple myeloma) ⋁
Evidence: 0.57
¬ Remarkable(albumin, be decreased in cirrhosis)
0.49
Rule weight: 0.85
Evidence weight: 0.75
Similarity weight: 0.78
Evidence: 0.72
Typical(albumin, decreased in multiple myeloma) ⋁
Evidence: 0.91
¬ Typical(albumin, be low in cancer patients)
0.49
Rule weight: 0.85
Evidence weight: 0.74
Similarity weight: 0.78
Evidence: 0.67
Plausible(albumin, decreased in multiple myeloma) ⋁
Evidence: 0.79
¬ Plausible(albumin, be low in cancer patients)
0.45
Rule weight: 0.85
Evidence weight: 0.69
Similarity weight: 0.77
Evidence: 0.55
Remarkable(albumin, decreased in multiple myeloma) ⋁
Evidence: 0.68
¬ Remarkable(albumin, be decreased in inflammation)

Typical and Remarkable implies Salient

0.12
Rule weight: 0.14
Evidence weight: 0.88
Similarity weight: 1.00
Evidence: 0.71
Salient(albumin, decreased in multiple myeloma) ⋁
Evidence: 0.72
¬ Typical(albumin, decreased in multiple myeloma) ⋁
Evidence: 0.55
¬ Remarkable(albumin, decreased in multiple myeloma)

Typical implies Plausible

0.37
Rule weight: 0.48
Evidence weight: 0.76
Similarity weight: 1.00
Evidence: 0.67
Plausible(albumin, decreased in multiple myeloma) ⋁
Evidence: 0.72
¬ Typical(albumin, decreased in multiple myeloma)

Typicality and Rermarkability incompatibility between siblings

0.06
Rule weight: 0.14
Evidence weight: 0.56
Similarity weight: 0.78
Evidence: 0.55
¬ Remarkable(albumin, decreased in multiple myeloma) ⋁
Evidence: 0.79
¬ Typical(hemoglobin, be low in cancer patients)